Gemini Space Station, Inc.
GEMI Nasdaq Finance Services Financials FY2023βFY2025
What Gemini Space Station, Inc. does
No business description yet.
- Legal name
- Gemini Space Station, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0002055592-26-000026
0002055592
Revenue and margins
Gemini Space Station, Inc. had $180M of revenue in fiscal 2025, up 26.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$220M in fiscal 2025, β122.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Gemini Space Station, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 663.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Gemini Space Station, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $32.8M | $42.8M | $252M |
| Current ratio | β | 1.0x | 1.3x |
| Quick ratio | β | 1.0x | 1.3x |
| Total assets | β | $1.6B | $1.8B |
| Total liabilities | β | $1.9B | $1.3B |
| Shareholders' equity | β$644M | β$795M | $541M |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 3 / 7 |
| Accruals ratio | β | β3.1% | β21.5% |
| Altman Z'' | β | β3.98 | β3.20 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $98.1M | $142M | $180M |
| Operating income | β$312M | β$166M | β$346M |
| Pretax income | β$324M | β$151M | β$589M |
| Income tax | β$4.1M | $7.6M | β$6.0M |
| Net income | β$320M | β$159M | β$583M |
| Diluted EPS | β$66.25 | β$32.24 | β$15.52 |
| Diluted shares | 0.00B | 0.00B | 0.04B |
| Cash flow | |||
| Cash from operations | β$207M | β$109M | β$218M |
| Capital expenditure | $0.7M | $1.2M | $2.0M |
| Free cash flow | β$208M | β$110M | β$220M |
| Depreciation and amortization | $32.2M | $33.0M | $30.7M |
| Stock-based compensation | $15.8M | $5.6M | $85.0M |
| Balance sheet | |||
| Cash and short-term investments | $32.8M | $42.8M | $252M |
| Current assets | β | $1.4B | $1.6B |
| Current liabilities | β | $1.3B | $1.2B |
| Property and equipment, net | β | $17.2M | $15.1M |
| Intangible assets | β | $162M | $140M |
| Total assets | β | $1.6B | $1.8B |
| Total liabilities | β | $1.9B | $1.3B |
| Preferred stock | β | $0.0M | $0.0M |
| Shareholders' equity | β$644M | β$795M | $541M |
| Margins | |||
| Operating margin | β317.5% | β116.6% | β192.5% |
| EBITDA margin | β284.7% | β93.5% | β175.4% |
| Net margin | β325.7% | β111.5% | β324.6% |
| FCF margin | β212.0% | β77.5% | β122.6% |
| Returns | |||
| Return on capital employed | β | β67.6% | β61.6% |
| Return on assets | β | β9.9% | β34.3% |
| Return on tangible equity | β | β | β145.3% |
| Growth | |||
| Revenue growth | β | 44.9% | 26.3% |
| Share count change | β | 1.9% | 663.6% |
| Financial health | |||
| Current ratio | β | 1.0x | 1.3x |
| Quick ratio | β | 1.0x | 1.3x |
| Capital allocation | |||
| Capex / revenue | 0.7% | 0.9% | 1.1% |
| Stock comp / revenue | 16.1% | 3.9% | 47.3% |
| Quality scores | |||
| Piotroski F-score | β | β | 3.0 |
| Altman Z'' | β | β4.0 | β3.2 |
| Accruals ratio | β | β3.1% | β21.5% |
Source: SEC EDGAR XBRL filings (CIK 0002055592). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.